Stomach Cancer Treatment: A Complete Guide

Stomach Cancer Treatment: A Complete Guide

Stomach Cancer Treatment: A Complete Guide
Everyday Health; Adobe Stock
Stomach cancer, also known as gastric cancer, begins in the cells that line the stomach. The vast majority of stomach cancers are the adenocarcinoma type, which affects the glandular mucus-producing cells of the innermost lining of the stomach.

Treatment of stomach cancer is multifaceted, involving a combination of surgery, chemotherapy, radiation, targeted therapy, immunotherapy, and supportive care. The choice of treatment depends on the cancer stage, your overall health, and personal preferences.

Stomach Cancer Staging

Your cancer stage guides your doctor in choosing the most effective treatment plan for you. The stages, which range from 0 through 4, refer to the extent of the cancer, or how far it has spread.

When talking about staging stomach cancer, it’s important to know the five layers of tissue and muscle that make up the stomach wall:

  • Mucosa, the innermost layer and the location where nearly all stomach cancers start
  • Submucosa, a supporting layer directly under the mucosa
  • Muscularis propria (muscle layer), a thick layer of muscle that moves and mixes the stomach contents
  • Subserosa, a layer of connective tissue between the muscle layer and the serosa
  • Serosa, the outer layer of the stomach that wraps around it

The stages of gastric cancer are as follows:

  • Stage 0 Also known as carcinoma in situ, stage 0 occurs when abnormal cells are growing in the mucosa, the innermost layer of your stomach wall. This is considered a “precancerous” condition rather than actual invasive cancer. These cells may become cancerous and spread to other normal tissue.
  • Stage 1 The cancer has spread into deeper layers of the stomach lining, such as the submucosa or muscle layer, and possibly to one or two nearby lymph nodes.
  • Stage 2 The cancer has spread to deeper layers (up to and maybe including the outer layer of the stomach) and more nearby lymph nodes, but it has not yet reached distant organs.
  • Stage 3 The cancer has spread to all layers of the stomach wall and more extensively to nearby lymph nodes. It may have also spread to one or more nearby organs or to the back of the abdomen.
  • Stage 4 The cancer has spread to distant parts of the body, such as the liver, lungs, distant lymph nodes, or tissue that lines the abdomen wall. Also known as metastatic stomach cancer, stage 4 stomach cancer develops when the cancer cells travel through the lymphatic or circulatory system and form tumors made up of stomach cancer cells (for instance, metastatic stomach cancer in the lungs are made of stomach cells, not lung cells).

Surgery for Stomach Cancer

Surgery is a standard treatment for stomach cancer, with the specific type of surgery depending on the cancer's location.

Surgery may be curative, which means the goal is to remove all the cancer, or palliative, which means it’s performed to address symptoms and to help prevent bleeding or blockages in the stomach. Palliative surgery is not intended to cure the cancer.

You may be treated with chemotherapy, sometimes combined with radiation (called chemoradiation), before surgery to make the cancer easier to remove and to preserve more healthy tissue. You may also receive chemotherapy, radiation, or both after surgery to kill any remaining cancer cells and reduce the risk of recurrence.

Curative Surgery for Stomach Cancer

There are several types of curative surgical procedures:

  • Endoscopic Resection For very early stage cancers, surgeons may guide an endoscope (a long, thin tube with a video camera at the end) through the mouth and throat into the stomach to remove the tumor.
  • Subtotal (Partial) Gastrectomy This procedure involves removing part of the stomach, depending on the tumor's location, and reattaching the remaining section of the stomach. Your surgeon may also remove nearby lymph nodes and parts of other nearby organs that may be affected, such as the esophagus, small intestine, or spleen.
  • Total Gastrectomy This procedure is for widespread cancers or those near the esophagus, and it involves removing the entire stomach, nearby lymph nodes and tissues, and the omentum (a layer of fatty tissue that covers the stomach and intestines). During a total gastrectomy, your surgeon will connect your esophagus to your small intestine after removing your stomach. It would require you to eat smaller, more frequent meals. If necessary, your surgeon may also remove parts of nearby organs that may be affected.
There are two surgical approaches for partial and total gastrectomy: open surgery and laparoscopic surgery. An open surgery is the traditional method with a large abdominal incision. Laparoscopic surgery involves the use of long, thin surgical instruments inserted into the abdomen through several small incisions, potentially with robotic assistance. This method may result in shorter recovery times.

Palliative Surgery for Stomach Cancer

Stomach cancer can cause issues like stomach blockage (if a tumor is blocking the stomach’s exit) and bleeding. Palliative surgery relieves such symptoms or complications. Types of palliative surgery include:

  • Gastric Bypass (Gastrojejunostomy) A tumor that is blocking the stomach's exit can be bypassed by connecting the upper stomach to the small intestine.
  • Subtotal Gastrectomy A part of the stomach is removed to relieve symptoms like bleeding or obstruction.
  • Feeding Tube Placement For patients who are unable to consume an adequate amount of food, a tube is placed directly into the stomach or small intestine to provide special high-nutrient food and fluids.
  • Endoluminal Stent Placement A stent is inserted to keep passages open that may have been blocked by tumors.
  • Endoluminal Laser Therapy Blockages are removed using an endoscope with a laser.

Surgery Complications and Side Effects

Surgery can lead to complications such as bleeding, infection, blood clots, and damage to nearby organs.

Post-operative side effects may include nausea, heartburn, pain, diarrhea, constipation, or fatigue.

You may experience nutritional deficiencies, necessitating dietary changes and possibly vitamin supplements. People who have had stomach cancer surgery typically need to eat smaller, more frequent meals, especially after a total gastrectomy.

Chemotherapy

Chemotherapy for stomach cancer is usually given intravenously (injected into a vein) or orally as pills, enabling the anticancer drugs to reach all parts of the body.

Chemotherapy may be used before and after surgery, and may also be used as a primary treatment for stomach cancer that has metastasized (spread to other areas) to help shrink the cancer and slow its growth.

There are many different chemotherapy drugs for stomach cancer, which may be prescribed alone or in combination with others. Commonly used chemotherapy drugs for stomach cancer include:

  • capecitabine
  • carboplatin
  • cisplatin
  • docetaxel
  • doxorubicin
  • epirubicin
  • fluorouracil (5-FU)
  • irinotecan
  • leucovorin
  • oxaliplatin
  • paclitaxel
  • trifluridine and tipiracil

Chemotherapy Side Effects

Chemotherapy side effects vary by drug type, dose, and treatment duration.

General side effects include:

  • Gastrointestinal issues such as nausea, vomiting, diarrhea, or constipation
  • Loss of appetite
  • Hair loss
  • Mouth sores
  • Increased infection risk from low white blood cell counts
  • Increased risk of bleeding and bruising from due low platelet counts
  • Fatigue and shortness of breath from low red blood cell counts

Additionally, some chemotherapy drugs carry specific side effects, such as:

  • Nerve damage or neuropathy (cisplatin, oxaliplatin, docetaxel, and paclitaxel)
  • Heart damage (epirubicin)
  • Hand-foot syndrome (capecitabine or 5-FU)
  • Severe diarrhea (irinotecan)

Inform your cancer care team about any side effects you experience from chemotherapy drugs, as there are often treatments available to improve these symptoms or other drugs that may be more suitable.

Radiation Therapy

Radiation therapy uses high-energy rays or particles to kill cancer cells in specific parts of the body. Like chemotherapy, it’s often used before or after surgery, but it can also be used to slow the growth of inoperable cancers and treat symptoms like pain, bleeding, and eating difficulties.

For stomach cancer, doctors use a technique called external beam radiation therapy, which directs radiation beams at the cancer from a machine outside of the body. Two special methods of giving external beam radiation therapy are:

  • Three-Dimensional Conformal Radiation Therapy (3D-CRT) Radiation of uniform intensity is aimed at the tumor from many directions, with beams conforming to the shape of the tumor.
  • Intensity Modulated Radiation Therapy (IMRT) Smaller radiation beams of different, specific intensities are directed at precise spots of the tumor.
Both these techniques are designed to minimize damage to nearby normal tissue.

Similar to an X-ray, external beam radiation therapy is painless and each session lasts a few minutes. Treatment usually occurs five days a week for several weeks.

Common side effects, which usually subside a few weeks after treatment, include:

  • Skin issues
  • Nausea
  • Vomiting
  • Diarrhea
  • Fatigue
  • Urinary and bladder problems

Targeted Therapy

Targeted therapy is a type of cancer treatment that uses drugs designed to identify and attack cancer cells without harming normal cells. These drugs target specific molecules involved in the growth, progression, and spread of cancer cells.

Targeted Therapy Drug Class
Drugs Approved for Stomach Cancer

HER2 Inhibitors

trastuzumab (Herceptin, Ogivri,

Herzuma, Ontruzant, Trazimera, Kanjinti)

fam-trastuzumab deruxtecan (Enhertu)

VEGF Inhibitors

ramucirumab (Cyramza)

TRK Inhibitors

larotrectinib (Vitrakvi)

entrectinib (Rozlytrek)

Monoclonal Antibodies

zolbetuximab-clzb (Vyloy)

HER2-Targeting Drugs

Some drugs for stomach cancer target the growth-promoting protein HER2, which is sometimes overproduced on the surface of cancer cells.

Trastuzumab (Herceptin, Ogivri, Herzuma, Ontruzant, Trazimera, Kanjinti) works by binding to the HER2 protein and blocking HER2-positive cells from sending chemical signals that tell them to grow, while also stimulating the immune system to kill cells with a lot of the HER2 protein. Side effects tend to be mild and include fever, chills, and nausea, though in rare cases it can cause heart damage.

Fam-trastuzumab deruxtecan (Enhertu) is a targeted drug linked to a chemotherapy drug. It works like a homing signal by attaching to the HER2 protein and bringing the chemotherapy drug directly to the cancer cell. It can cause mild side effects similar to trastuzumab, as well as an increased risk of infections and bleeding, hair loss, serious lung disease, and rare heart damage.

VEGF-Targeting Drugs

This class of drugs targets the vascular endothelial growth factor (VEGF) receptor, which is involved in the formation of new blood vessels (called angiogenesis) that tumors need to grow.

Ramucirumab (Cyramza) works by binding to VEGF receptors on cancer cells. This blocks VEGF from binding to these cells and prevents them from making more blood vessels, ultimately slowing or stopping the growth of the cancer.

Common side effects include high blood pressure, headache, and diarrhea. Less often, more serious side effects can develop, including:

  • Blood clots
  • Severe bleeding
  • The formation of holes or perforations in the stomach or intestines
  • Issues with wounds healing

TRK Inhibitors

Rarely, some stomach cancers may have mutations in one of the NTRK genes, which causes the production of abnormal TRK proteins, leading to abnormal cell growth and cancer. The TRK inhibitors larotrectinib (Vitrakvi) and entrectinib (Rozlytrek) work by targeting these abnormal proteins. Side effects are usually mild, and include:


  • Dizziness
  • Fatigue
  • Nausea
  • Vomiting
  • Constipation
  • Weight gain
  • Diarrhea
Serious and uncommon side effects include abnormal liver tests, heart problems, and confusion.

Monoclonal Antibodies

Monoclonal antibodies are proteins created in a lab that can bind to certain targets on a cell’s surface.

Zolbetuximab-clzb (Vyloy) is currently the only monoclonal antibody approved for the treatment of stomach cancer. It’s used along with chemotherapy and administered intravenously. 

Common side effects include vomiting, nausea, diarrhea, fever, and decreased appetite. Serious side effects include low white blood cells, intestinal obstruction, pneumonia, respiratory failure, pulmonary embolism, and sepsis.

Immunotherapy

Immunotherapy helps the immune system target and destroy cancer cells. A key method is checkpoint inhibitors. Normal cells have checkpoint proteins on their surface that prevent the immune system from attacking them. Cancer cells can use these proteins to hide from the immune system.

PD-1 inhibitors are a type of immunotherapy drug that blocks the PD-1 checkpoint protein on T cells (a type of immune system cell). Inhibiting this protein allows the T-cells to attack cancer cells. Two PD-1 inhibitors used to treat stomach cancer are nivolumab (Opdivo) and pembrolizumab (Keytruda).

Possible side effects of these drugs include:

  • Fatigue
  • Fever
  • Cough
  • Nausea
  • Itching or skin rash
  • Appetite loss
  • Muscle or joint pain
  • Shortness of breath
  • Constipation or diarrhea

In more serious cases, the drugs can cause infusion reactions (similar to allergic reactions) and autoimmune reactions, which may prevent their further use.

Clinical Trials

Clinical trials are research studies that test new treatments, drugs, or procedures to determine their safety and effectiveness. Participants in clinical trials gain access to cutting-edge therapies not yet available to the general public.

There are many clinical trials being conducted at any given time, and they span a range of different topics.

Clinical trials may seek to:
  • Test the effectiveness of a new drug
  • Investigate innovative treatment techniques and therapies
  • Identify genetic or molecular markers that predict response to certain treatments
  • Assess how interventions or supportive care strategies can improve the quality of life for patients undergoing treatment
  • Develop new screening methods or preventive measures to detect stomach cancer earlier or reduce the risk of developing the disease

If you’re interested in finding out about joining a clinical trial, you can start by asking your doctor if you may be eligible to join one. You can also do a search on ClinicalTrials.gov, an online resource maintained by the National Library of Medicine, where clinical studies are registered and updated.

Palliative Care

Palliative care is a specialized approach aimed at improving the quality of life for patients with serious or life-threatening diseases like cancer. It focuses on alleviating symptoms, side effects, and associated psychological, social, and spiritual issues, while addressing the patient as a whole.

Palliative care can be given alongside curative treatments, and is suitable at any stage of disease and for any age. Palliative care is delivered by multidisciplinary teams that include palliative care specialists and various healthcare professionals who work with oncology teams to ensure comprehensive patient and caregiver support. Research indicates that early integration of palliative care in cancer treatment can improve quality of life, mood, and potentially prolong survival.

The Takeaway

  • Stomach cancer treatment requires a multifaceted approach — including surgery, chemotherapy, radiation, and newer options like targeted therapy and immunotherapy — to remove, shrink, or slow the growth of cancer cells.
  • As your healthcare team considers the best treatment plan for you, they will take into account your cancer stage, your overall health, and your personal preferences.
  • Integrate palliative care early in your cancer journey to enhance your quality of life and even improve survival.
nimit-sudan-bio

Nimit Sudan, MD

Medical Reviewer

Nimit Sudan, MD, is a hematologist and medical oncologist with UCLA. He is an assistant clinical professor at UCLA and serves as a lead physician at the Encino community practice. He has a special interest in integrative medicine and oncology.

Dr. Sudan provides comprehensive care for adult patients with all types of hematologic and oncologic conditions. His mission is to treat every patient with the utmost compassion and care, and to develop a strong doctor-patient relationship. He is passionate about patient and family education, and educating larger communities on cancer awareness and prevention. He also has a special interest in integrative medicine, and is certified in acupuncture.

Sudan is from the Midwest, and received both his medical degree and bachelor's degree from Wayne State University in Detroit, Michigan. He completed his internal medicine residency at the Cleveland Clinic Foundation, and his hematology/oncology fellowship at Western Pennsylvania Hospital in Pittsburgh.

Joseph Bennington-Castro

Author

Joseph Bennington-Castro is a science writer based in Hawaii. He has written well over a thousand articles for the general public on a wide range topics, including health, astronomy, archaeology, renewable energy, biomaterials, conservation, history, animal behavior, artificial intelligence, and many others.

In addition to writing for Everyday Health, Bennington-Castro has also written for publications such as Scientific American, National Geographic online, USA Today, Materials Research Society, Wired UK, Men's Journal, Live Science, Space.com, NBC News Mach, NOAA Fisheries, io9.com, and Discover.

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. What Is Stomach Cancer? National Cancer Institute.
  2. Stomach Cancer Treatment. National Cancer Institute. May 31, 2023.
  3. Stomach Cancer Stages. American Cancer Society. January 22, 2021.
  4. Stomach Cancer Stages. National Cancer Institute.
  5. Surgery for Stomach Cancer. American Cancer Society. January 22, 2021.
  6. Stomach Cancer: Surgery. University of Rochester Medical Center.
  7. Stomach Cancer Treatment. National Cancer Institute. May 31, 2023.
  8. Chemotherapy to Treat Cancer. National Cancer Institute.
  9. Chemotherapy for Stomach Cancer. American Cancer Society. January 22, 2021.
  10. Radiation Therapy for Stomach Cancer. American Cancer Society. January 22, 2021.
  11. Stomach Cancer: Radiation Therapy. UW Medicine. October 1, 2023.
  12. Radiation Therapy Side Effects. National Cancer Institute. January 11, 2022.
  13. Targeted Drug Therapy for Stomach Cancer. American Cancer Society. January 22, 2021.
  14. Monoclonal Antibody. National Cancer Institute.
  15. FDA Approves Zolbetuximab-clzb With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma. U.S. Food and Drug Administration. October 18, 2024.
  16. Immunotherapy for Stomach Cancer. American Cancer Society. November 21, 2023.
  17. What Are Clinical Trials? National Cancer Institute. November 3, 2024.
  18. Palliative Care in Cancer. National Cancer Institute. November 1, 2021.